Results per Page:
Engineering B cells to improve HIV treatments
From the Kiem lab, Translational Sciences and Therapeutics Division
The benefits of HIV research? Let us count the ways
HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases
Numerous medical advances originate from U.S.-funded HIV research
HIV reservoir decay rates defined for children receiving ART
From Dr. Daniel Reeves and colleagues, Fred Hutch Vaccine & Infectious Disease Division and UW Global Health
CARD8: the ‘tripwire’ inside cells that alerts the body to HIV
From the Emerman and Mitchell labs, Human Biology Division and University of Washington
Do we still need an HIV vaccine now that we have a twice-a-year prevention shot?
From the Kublin lab, Vaccine and Infectious Disease Division
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science
Award recognizes leadership in HIV vaccine trial development, analysis
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
Early suppression of HIV in mothers reduces childhood health risks
From Dr. Emily Begnel, UW and Dr. Dara Lehman, Human Biology Division Fred Hutch
Breaking down barriers to clinical trial participation for people living with HIV
From the Menon group, Vaccine and Infectious Disease Division
HIV’s secret sweet tooth: T cell glycosylation determines variant entry
From the Overbaugh Lab, Human Biology and Public Health Sciences Divisions
Bottleneck breakthrough
Fred Hutch researchers discover why some HIV-1 variants are more transmissible than others, which could generate new approaches to stop the virus that causes AIDS at cell entry
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor.
Experimental Phase 2b HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV
No safety signals of concern for study participants
New bacterium named in honor of Fred Hutch
First organism named after research center linked to bacterial vaginosis, higher HIV risk